ALGYX | GFAFX | ALGYX / GFAFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 24 years | - |
Gain YTD | 51.269 | 28.462 | 180% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 250 | 200,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.99B | 302B | 1% |
Annual Yield % from dividends | 0.11 | 0.45 | 24% |
Returns for 1 year | 56.98 | 28.10 | 203% |
Returns for 3 years | 20.33 | -0.84 | -2,418% |
Returns for 5 years | 110.39 | 55.20 | 200% |
Returns for 10 years | N/A | 71.37 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHPSX | 22.86 | 0.54 | +2.42% |
ProFunds Pharmaceuticals UltraSector Svc | |||
VVOIX | 24.24 | 0.49 | +2.06% |
Invesco Value Opportunities Y | |||
GTHCX | 19.85 | 0.10 | +0.51% |
Invesco Health Care C | |||
STRCX | 10.03 | 0.04 | +0.40% |
Sterling Capital Behavioral Intl Eq R6 | |||
FERIX | 50.32 | -0.32 | -0.63% |
Fidelity Advisor Emerging Asia I |